HPV Diagnostics, Condom Labeling Will Be Focus Of Jan. 28 House Hearing
This article was originally published in The Gray Sheet
Executive Summary
FDA and the National Cancer Institute are among federal agencies asked to testify on cervical cancer prevention and research at a Jan. 28 hearing of the House Government Reform/Human Resources Subcommittee